stock.name

Exact Sciences Corp.

EXAS

Market Cap$9.59B
Close$

Compare Exact Sciences

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Exact Sciences Corp.Exact Sciences Corp.-39.90%-8%3.90.8
marketMarket Avg53.21.27%29%-1.3
HealthcareHealthcare Avg29.71.32%16%7.31.3
$85.00

Target Price by Analysts

68.7% upsideExact Sciences Target Price DetailsTarget Price
$72.07

Current Fair Value

43.1% upside

Undervalued by 43.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$9.59 Billion
Enterprise Value$11.30 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.33
Beta1.55
Outstanding Shares184,529,721
Avg 30 Day Volume2,853,718

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-39.91
PEG-82.02
Price to Sales3.88
Price to Book Ratio3.15
Enterprise Value to Revenue4.46
Enterprise Value to EBIT-35.56
Enterprise Value to Net Income-48
Total Debt to Enterprise0.21
Debt to Equity0.76

Revenue Sources

No data

ESG Score

No data

About Exact Sciences Corp.

CEO: Kevin Conroy